SLC16A3 and esophageal adenocarcinoma: High MCT4 expression has been shown to correlate with enhanced metastatic processes, especially in oesophageal adenocarcinoma [23] and in colorectal carcinoma [24, 25], and with invasion in gastric cancer [26].